- Home
- NUE vs TAK Comparison
NUE vs TAK Comparison
Compare NUE & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUE | TAK |
|---|---|---|
| Founded | 1905 | 1781 |
| Country | United States | Japan |
| Employees | N/A | 47029 |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.7B | 55.1B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | NUE | TAK |
|---|---|---|
| Price | $257.70 | $17.18 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $209.60 | N/A |
| AVG Volume (30 Days) | 1.3M | ★ 3.5M |
| Earning Date | 04-27-2026 | 05-13-2026 |
| Dividend Yield | 1.01% | ★ 3.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.23 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.07 | $0.16 |
| Revenue Next Year | $4.14 | $1.22 |
| P/E Ratio | $79.26 | ★ $41.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $131.32 | $12.99 |
| 52 Week High | $270.90 | $18.90 |
Technical Indicators
Market Signals| Indicator | NUE | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 62.03 | 69.75 |
| Support Level | $245.33 | $17.65 |
| Resistance Level | $267.78 | $18.74 |
| Average True Range (ATR) | 7.12 | 0.25 |
| MACD | 3.42 | 0.08 |
| Stochastic Oscillator | 70.30 | 94.98 |
Price Performance
Historical ComparisonAbout NUE Nucor Corporation
Nucor Corp manufactures steel and steel products. The company's reportable segments are steel mills, steel products, and raw materials. The majority of its revenue is derived from the steel mills segment, which is engaged in producing sheet steel (hot-rolled, cold-rolled, and galvanized), plate steel, structural steel (wide-flange beams, beam blanks, H-piling, and sheet piling), and bar steel products. Nucor manufactures steel principally from scrap steel and scrap steel substitutes using electric arc furnaces (EAFs), along with continuous casting and automated rolling mills. The steel mills segment sells its products mainly to steel service centers, fabricators, and manufacturers located in the United States, Canada, and Mexico.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.